Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies

Philipp A. Ilinykh, Jessica Graber, Natalia A. Kuzmina, Kai Huang, Thomas Ksiazek, James E. Crowe, Alexander Bukreyev

Research output: Contribution to journalArticle

Abstract

Screening of monoclonal antibodies against ebolaviruses requires small-animal models. Wild-type mice require adaptation of ebolaviruses, whereas immunodeficient mice are still resistant to nonadapted Bundibugyo ebolavirus. Swapping of Ebola virus glycoprotein with that from Bundibugyo virus resulted in a replication-competent chimeric virus, which caused 100% lethal infection in STAT1 knockout mice. Monoclonal antibody BDBV223 isolated from a human survivor of Bundibugyo virus infection protected mice from challenge with the chimeric virus. These data demonstrate the suitability of the approach for in vivo screening of antibodies and suggest the greater contribution of internal Ebola proteins in pathogenesis compared to Bundibugyo virus proteins.

Original languageEnglish (US)
Pages (from-to)S418-S422
JournalThe Journal of infectious diseases
Volume218
Issue number5
DOIs
StatePublished - Nov 22 2018

Fingerprint

Ebolavirus
Viruses
Antibodies
Monoclonal Antibodies
Virus Diseases
Knockout Mice
Glycoproteins
Proteins
Animal Models
Infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies. / Ilinykh, Philipp A.; Graber, Jessica; Kuzmina, Natalia A.; Huang, Kai; Ksiazek, Thomas; Crowe, James E.; Bukreyev, Alexander.

In: The Journal of infectious diseases, Vol. 218, No. 5, 22.11.2018, p. S418-S422.

Research output: Contribution to journalArticle

@article{ec3b4ea317124eefaee0ea1b731c1e64,
title = "Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies",
abstract = "Screening of monoclonal antibodies against ebolaviruses requires small-animal models. Wild-type mice require adaptation of ebolaviruses, whereas immunodeficient mice are still resistant to nonadapted Bundibugyo ebolavirus. Swapping of Ebola virus glycoprotein with that from Bundibugyo virus resulted in a replication-competent chimeric virus, which caused 100{\%} lethal infection in STAT1 knockout mice. Monoclonal antibody BDBV223 isolated from a human survivor of Bundibugyo virus infection protected mice from challenge with the chimeric virus. These data demonstrate the suitability of the approach for in vivo screening of antibodies and suggest the greater contribution of internal Ebola proteins in pathogenesis compared to Bundibugyo virus proteins.",
author = "Ilinykh, {Philipp A.} and Jessica Graber and Kuzmina, {Natalia A.} and Kai Huang and Thomas Ksiazek and Crowe, {James E.} and Alexander Bukreyev",
year = "2018",
month = "11",
day = "22",
doi = "10.1093/infdis/jiy423",
language = "English (US)",
volume = "218",
pages = "S418--S422",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies

AU - Ilinykh, Philipp A.

AU - Graber, Jessica

AU - Kuzmina, Natalia A.

AU - Huang, Kai

AU - Ksiazek, Thomas

AU - Crowe, James E.

AU - Bukreyev, Alexander

PY - 2018/11/22

Y1 - 2018/11/22

N2 - Screening of monoclonal antibodies against ebolaviruses requires small-animal models. Wild-type mice require adaptation of ebolaviruses, whereas immunodeficient mice are still resistant to nonadapted Bundibugyo ebolavirus. Swapping of Ebola virus glycoprotein with that from Bundibugyo virus resulted in a replication-competent chimeric virus, which caused 100% lethal infection in STAT1 knockout mice. Monoclonal antibody BDBV223 isolated from a human survivor of Bundibugyo virus infection protected mice from challenge with the chimeric virus. These data demonstrate the suitability of the approach for in vivo screening of antibodies and suggest the greater contribution of internal Ebola proteins in pathogenesis compared to Bundibugyo virus proteins.

AB - Screening of monoclonal antibodies against ebolaviruses requires small-animal models. Wild-type mice require adaptation of ebolaviruses, whereas immunodeficient mice are still resistant to nonadapted Bundibugyo ebolavirus. Swapping of Ebola virus glycoprotein with that from Bundibugyo virus resulted in a replication-competent chimeric virus, which caused 100% lethal infection in STAT1 knockout mice. Monoclonal antibody BDBV223 isolated from a human survivor of Bundibugyo virus infection protected mice from challenge with the chimeric virus. These data demonstrate the suitability of the approach for in vivo screening of antibodies and suggest the greater contribution of internal Ebola proteins in pathogenesis compared to Bundibugyo virus proteins.

UR - http://www.scopus.com/inward/record.url?scp=85057162929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057162929&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiy423

DO - 10.1093/infdis/jiy423

M3 - Article

VL - 218

SP - S418-S422

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -